Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Chemotherapy Associated NeutropeniaBreast Cancer
Interventions
DRUG

EP2006

Eligible patients will be teated with EP2006

DRUG

Filgrastim

Eligible patients will be teated with Filgrastim

Trial Locations (26)

1125

Semmelweis Egyetem, III. Belgyogyaszati Klinika, Budapest

1145

Fovarosi Onkormanyzat Uzsoki utcai Korhaz, Onkoradiologia, Budapest

4032

DE OEC, Onkologiai Tanszek, Debrecen

4400

Josa Andras Oktato Korhaz Nonprofit Kft, Nyíregyháza

5400

Daugavpils Regional Hospital, Daugavpils

8000

Fejer Megyei Szent Gyorgy Korhaz, Onkologiai Osztaly, Székesfehérvár

9700

Vas Megyei Markusovszky Korhaz, Onkoradiologiai Osztaly, Szombathely

21029

Vinnytsya Regional Clinical Oncological Center, Chemotherapy Department, Vinnitsya

26204

Insitut Onkologie a Rehabilitaca na Plesi, Ves Pod Plesi 110

49102

"Communal Institution Dnipropetrovsk Сity multiple-discipline Clinical Hospital 4 of Dnipropetrovsk Regional Council", Dnipropetrovsk

50048

"Communal Institution Krivorizhskiy oncology dispensary of Dnipropetrovsk regional Council, Chemotherapy Department", Kryvyi Rih

65025

"Communal Institution Odesa regional clinical hospital, Mammology Center", Odesa

79031

Lviv state oncological regional treatment-and-diagnostics center, Chemotherapy Department, Lviv

91000

"Medical center of Limited Liability Company Inter", Luhansk

95001

Fakultna nemocnica Nitra, Oddelenie radioterapie a klinickej onkologie, Nitra

115478

"Institution of the Russian Academy of Medical Sciences Russian Oncology Research Center n.a. N.N.Blochin of RAMS, Surgery Department of the Female Reproductive System Tumors", Moscow

143423

Institution of the Russian Academy of Medical Sciences Medical Radiology Research Center RAMS, Moscow

188663

"State Healthcare Institution (SHI) Leningrad Regional Oncological Dispensary at the Surgery Department 2", Kuzmolovsky

195271

Non-State Healthcare Institution NSHI, Saint Petersburg

197022

"Saint-Petersburg State Healthcare Institution (SPb SHI) City Clinical Oncological Dispensary", Saint Petersburg

249036

Institution of the Russian Academy of Medical Sciences Medical Radiology Research Center RAMS, Obninsk

350040

"State Healthcare Institution (SHI) Clinical Oncological Dispensary №1 of Healthcare Department of Krasnodar Territory", Krasnodar

357502

State Healthcare Institution SHI Pyatigorsk Oncological Dispensary, Pyatigorsk

394000

"State Healthcare Institution (SHI)Voronezh Regional Clinical Oncological Dispensary", Voronezh

454087

State Medical-Prophylactic Institution SMPI Reginal Clinical Oncological Dispensary, Chelyabinsk

603081

"Affiliate No1 of State Healthcare Institution (SHI) Nizhny Novgorod Regional Oncological Dispensary", Nizhny Novgorod

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT01519700 - Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim | Biotech Hunter | Biotech Hunter